Literature DB >> 22500646

Treating pediatric migraine: an expert opinion.

Hope L O'Brien1, Marielle A Kabbouche, Andrew D Hershey.   

Abstract

INTRODUCTION: Headaches are common in children and adolescents and migraine affects almost 8% of this population. As revisions are made to the ICHD-II criteria to include additional characteristics of pediatric migraine, the diagnosis of migraine is expected to increase. Therefore, it is important to understand and apply successful treatment in acute migraine. Patients and families should be educated about the options for migraine treatment that includes both pharmacologic and conservative behavioral techniques in managing headaches. AREAS COVERED: This review examines the studies that have been performed in pediatric patients, in addition to exploring the treatment options commonly used in pediatrics and adolescents for migraine and their rationale for use. EXPERT OPINION: For the acute treatment of migraine, we recommend the use of ibuprofen or acetaminophen for mild, moderate or severe headache. For moderate to severe headache, or for headaches that fail to respond to over-the-counter medications, we recommend the use of a triptan or combination NSAID/triptan therapy. For preventative treament of migraine, cyproheptadine should be reserved for younger children unable to swallow tablets while amitriptyline is preferred due to its once daily dosing and minimal side effects. Topiramate and divalproate are considerable options depending on patient co-morbid profile and preference.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22500646     DOI: 10.1517/14656566.2012.677434

Source DB:  PubMed          Journal:  Expert Opin Pharmacother        ISSN: 1465-6566            Impact factor:   3.889


  15 in total

Review 1.  New Developments in the Prophylactic Drug Treatment of Pediatric Migraine: What Is New in 2017 and Where Does It Leave Us?

Authors:  Joanne Kacperski; Allyson Bazarsky
Journal:  Curr Pain Headache Rep       Date:  2017-08

2.  Differential changes in functional disability and pain intensity over the course of psychological treatment for children with chronic pain.

Authors:  Anne M Lynch-Jordan; Soumitri Sil; James Peugh; Natoshia Cunningham; Susmita Kashikar-Zuck; Kenneth R Goldschneider
Journal:  Pain       Date:  2014-06-20       Impact factor: 6.961

Review 3.  Preventive drugs in childhood and adolescent migraine.

Authors:  Joanne Kacperski; Andrew D Hershey
Journal:  Curr Pain Headache Rep       Date:  2014-06

Review 4.  Adolescent fatigue, POTS, and recovery: a guide for clinicians.

Authors:  Sarah J Kizilbash; Shelley P Ahrens; Barbara K Bruce; Gisela Chelimsky; Sherilyn W Driscoll; Cynthia Harbeck-Weber; Robin M Lloyd; Kenneth J Mack; Dawn E Nelson; Nelly Ninis; Paolo T Pianosi; Julian M Stewart; Karen E Weiss; Philip R Fischer
Journal:  Curr Probl Pediatr Adolesc Health Care       Date:  2014 May-Jun

Review 5.  The optimal management of headaches in children and adolescents.

Authors:  Joanne Kacperski; Marielle A Kabbouche; Hope L O'Brien; Jessica L Weberding
Journal:  Ther Adv Neurol Disord       Date:  2016-01       Impact factor: 6.570

Review 6.  Prophylactic Drug Treatment of Migraine in Children and Adolescents: An Update.

Authors:  János Tajti; Délia Szok; Anett Csáti; László Vécsei
Journal:  Curr Pain Headache Rep       Date:  2016-01

Review 7.  Pharmacotherapy for Persistent Posttraumatic Headaches in Children and Adolescents: A Brief Review of the Literature.

Authors:  Joanne Kacperski
Journal:  Paediatr Drugs       Date:  2018-10       Impact factor: 3.022

Review 8.  Prophylaxis of migraine in children and adolescents.

Authors:  Joanne Kacperski
Journal:  Paediatr Drugs       Date:  2015-06       Impact factor: 3.022

Review 9.  Newly Approved Agents for the Treatment and Prevention of Pediatric Migraine.

Authors:  Joanne Kacperski; Andrew D Hershey
Journal:  CNS Drugs       Date:  2016-09       Impact factor: 5.749

10.  Relationship between daily mood and migraine in children.

Authors:  Cynthia W Karlson; Catrina C Litzenburg; Marilyn L Sampilo; Michael A Rapoff; Mark Connelly; Jennifer L Bickel; Andrew D Hershey; Scott W Powers
Journal:  Headache       Date:  2013-09-19       Impact factor: 5.887

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.